The animal health market has demonstrated a recession-proof nature uncommon to most industries. Given the attractiveness of the veterinary market, a number of innovators, entrepreneurs, and investors are being drawn to the space. While the financial hurdles and time to approval are lower in veterinary medicine than in human, it remains critically important to understand the market and the technical requirements expected in animal health. Tom Overbay of Expedite Animal Health addresses the importance of applying a disciplined approach to this process, fundamental to avoid errors in market expectations and forecasting, as well as to ensure an efficient approach to development of animal health products.